key: cord-0905502-zgxkwcgl authors: Ito, Kimihito; Piantham, Chayada; Nishiura, Hiroshi title: Relative instantaneous reproduction number of Omicron SARS‐CoV‐2 variant with respect to the Delta variant in Denmark date: 2022-01-11 journal: J Med Virol DOI: 10.1002/jmv.27560 sha: fb114ba8297a1171ff9938004a559fcc2d034f54 doc_id: 905502 cord_uid: zgxkwcgl The Omicron variant of the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has become widespread across the world in a flashing manner. As of December 7, 2021, a total of 758 Omicron cases were confirmed in Denmark. Using the nucleotide sequences of the Delta and Omicron variants registered from Denmark in the GISAID database, we found that the effective (instantaneous) reproduction number of Omicron is 3.19 (95% confidence interval [CI]: 2.82–3.61) times greater than that of Delta under the same epidemiological conditions. The proportion of Omicron infections among all SARS‐CoV‐2 infections in Denmark was expected to exceed 95% on December 28, 2021, with a 95% CI from December 25 to December 31, 2021. Given that the Delta variant or variants less transmissible than Delta are dominant in most countries, the rapid increase in Omicron in the virus population may be observed as soon as the Omicron is introduced. Preparing proactive control measures is vital, assuming the substantial advantage of the transmission by Omicron. Since its designation as a variant of concern by the World Health Organization on November 22, 2021, 1 the Omicron variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become widespread across the world in a flashing manner. As of December 14, 2021, Omicron has been confirmed in 76 countries. 2 Datasets from countries with the early spread of Omicron suggest that Omicron is more transmissible than the Delta variant. Pulliam et al. 3 found that Omicron had a substantial ability to evade immunity from prior infections with other variants or vaccination. Kuhlmann et al. 4 reported that Omicron infected individuals who were fully vaccinated and those who had additional booster shots. Rössler et al. 5 found that titers of sera from vaccinated individuals to neutralize Omicron was much lower than any other analyzed variants. Using frequencies of nucleotide sequences of Omicron and other variants identified in Gauteng province, South Africa, Nishiura et al. 6 estimated that the reproduction number of Omicron was 4.2 times (95% confidence interval [CI]: 2.1, 9.1) greater than that of the Delta variant. As of December 7, 2021, a total of 758 Omicron cases were confirmed in Denmark. 7 Given high coverage of COVID-19 vaccination in the country, 76% of these Omicron patients had received two doses of vaccination and an additional 7.1% had three doses. The daily number of newly diagnosed cases in Denmark is swiftly growing. It is natural to think of this increase in the number of SARS-CoV-2 infections as the result of a rapid increase in the proportion of Omicron among the SARS-CoV-2 population in Denmark. Denmark is one of the countries having the highest wholegenome sequencing (WGS) capacities for SARS-CoV-2. As of December 17, the WGS rate of the country was 0.572 sequence per confirmed cases for the 48th week (from November 29 to December 5) of 2021. 8 In our previous paper, we have developed a method to estimate the relative instantaneous reproduction number, R RI , of a variant with respect to (w.r.t.) another variant using time series of the numbers of observations of each variant. 9 The R RI of a target The R RI of Omicron w.r.t. Delta was calculated using the method proposed by Ito et al. 9 Briefly, the R RI of Omicron w.r.t. Delta at are instantaneous reproduction numbers of infections by Omicron and Delta at calendar time t, respectively. 11 Assuming that R RI of Omicron w.r.t. Delta has a constant value of s 1 + over time and that no lineages other than Omicron or Delta is circulating in the population, the frequency of Omicron in the population at time t, q t ( ) Omicron , can be represented as As of December 18, 2021, the GISAID database has a total of 61,372 records of nucleotide sequences that were collected and submitted from Denmark. 10 Of these, 61,093 sequences were assigned to PANGO lineages corresponding to Delta and 272 sequences were assigned to those of Omicron in the metadata provided by the GISAID database. 12 The remaining seven sequences were assigned to lineages other than Delta or Omicron and these were ignored in the subsequent analyses. The date of sample collection of the earliest Omicron sequence was November 22, 2021. The information on dates of sample collection and PANGO lineages of these sequences are provided in Table S1 . infections will increase more than threefolds within a matter of a month. Our estimates from Danish data were consistent with the other one from Gauteng, South Africa. 6 The authors gratefully acknowledge the laboratories responsible for obtaining the specimens and the laboratories where genetic sequence data were generated and shared via the GISAID Initiative, on which this study is based. The information on originating laboratories, submitting laboratories, and authors of SARS-CoV-2 sequence data can be found in World Health Organization. Tracking SARS-CoV-2 variants Weekly epidemiological update on COVID-19-14 Increased risk of SARS-CoV-2 reinfection associated with emergence of the Omicron variant in South Africa. medRxiv Breakthrough infections with SARS-CoV-2 Omicron variant despite booster dose of mRNA vaccine SARS-CoV-2 B.1.1.529 variant (Omicron) evades neutralization by sera from vaccinated and convalescent individuals. medRxiv Omicron (B.1.1.529) compared with Delta variant in South Africa Epidemiological characterisation of the first 785 SARS-CoV-2 Omicron variant cases in Denmark Genomic overview of SARS-CoV-2 in Denmark Predicted dominance of variant Delta of SARS-CoV-2 before Tokyo Olympic Games Global initiative on sharing all influenza data-from vision to reality Estimating individual and household reproduction numbers in an emerging epidemic A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology Serial interval of novel coronavirus (COVID-19) infections SUPPORTING INFORMATION Additional supporting information may be found in the online version of the article at the publisher's website. How to cite this article: Ito K, Piantham C, Nishiura H. Relative instantaneous reproduction number of Omicron SARS-CoV-2 variant with respect to the Delta variant in The authors declare that there are no conflict of interests. Kimihito Ito and Chayada Piantham collected data and conducted estimation. Hiroshi Nishiura addressed public health implications.Kimihito Ito, Chayada Piantham, and Hiroshi Nishiura wrote the paper.